169 related articles for article (PubMed ID: 9467351)
1. Extracts of Prevotella intermedia and Actinobacillus actinomycetemcomitans inhibit alkaline phosphatase activity in osteoblastic cells in vitro.
Murata T; Ansai T; Takehara T; Kobayashi S; Haneji T
Oral Dis; 1997 Jun; 3(2):106-12. PubMed ID: 9467351
[TBL] [Abstract][Full Text] [Related]
2. Extracts of Actinobacillus actinomycetemcomitans induce apoptotic cell death in human osteoblastic MG63 cells.
Morimoto Y; Morimoto H; Murata T; Kobayashi S; Ohba T; Haneji T
J Dent Res; 1999 Mar; 78(3):735-42. PubMed ID: 10096448
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharides from Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans promote osteoclastic differentiation in vitro.
Ito HO; Shuto T; Takada H; Koga T; Aida Y; Hirata M; Koga T
Arch Oral Biol; 1996 May; 41(5):439-44. PubMed ID: 8809306
[TBL] [Abstract][Full Text] [Related]
4. Effects of lipopolysaccharide extracted from Prevotella intermedia on bone formation and on the release of osteolytic mediators by fetal mouse osteoblasts in vitro.
Pelt P; Zimmermann B; Ulbrich N; Bernimoulin JP
Arch Oral Biol; 2002 Dec; 47(12):859-66. PubMed ID: 12450517
[TBL] [Abstract][Full Text] [Related]
5. Enumeration of Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans in subgingival plaque samples by a quantitative-competitive PCR method.
Doungudomdacha S; Rawlinson A; Douglas CW
J Med Microbiol; 2000 Oct; 49(10):861-74. PubMed ID: 11023183
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora.
Johansson A; Hänström L; Kalfas S
Oral Microbiol Immunol; 2000 Aug; 15(4):218-25. PubMed ID: 11154406
[TBL] [Abstract][Full Text] [Related]
7. Characterization of inhibitory effects of suspected periodontopathogens on osteogenesis in vitro.
Loomer PM; Ellen RP; Tenenbaum HC
Infect Immun; 1995 Sep; 63(9):3287-96. PubMed ID: 7642257
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the lactoferrin-dependent inhibition of the adhesion of Actinobacillus actinomycetemcomitans, Prevotella intermedia and Prevotella nigrescens to fibroblasts and to a reconstituted basement membrane.
Alugupalli KR; Kalfas S
APMIS; 1997 Sep; 105(9):680-8. PubMed ID: 9350211
[TBL] [Abstract][Full Text] [Related]
9. Analytical performance of an immunologic-based periodontal bacterial test for simultaneous detection and differentiation of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia.
Snyder B; Ryerson CC; Corona H; Grogan EA; Reynolds HS; Contestable PB; Boyer BP; Mayer J; Mangan T; Norkus N; Zambon JJ; Genco RJ
J Periodontol; 1996 May; 67(5):497-505. PubMed ID: 8724708
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia in an Australian population.
Hamlet SM; Cullinan MP; Westerman B; Lindeman M; Bird PS; Palmer J; Seymour GJ
J Clin Periodontol; 2001 Dec; 28(12):1163-71. PubMed ID: 11737515
[TBL] [Abstract][Full Text] [Related]
11. Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella intermedia over a 5-year period: effect of a triclosan/copolymer dentifrice.
Cullinan MP; Hamlet SM; Westerman B; Palmer JE; Faddy MJ; Seymour GJ
J Clin Periodontol; 2003 Jun; 30(6):532-41. PubMed ID: 12795792
[TBL] [Abstract][Full Text] [Related]
12. Degradation of lactoferrin by periodontitis-associated bacteria.
Alugupalli KR; Kalfas S
FEMS Microbiol Lett; 1996 Dec; 145(2):209-14. PubMed ID: 8961558
[TBL] [Abstract][Full Text] [Related]
13. Effective method for discriminating between oral bacterial and human alkaline phosphatase activity.
Shibata Y; Yamashita Y; Miyazaki H; Ueno S; Takehara T
Oral Microbiol Immunol; 1994 Feb; 9(1):35-9. PubMed ID: 7478753
[TBL] [Abstract][Full Text] [Related]
14. Persistent bacterial colonization of Porphyromonas gingivalis, Prevotella intermedia, and Actinobacillus actinomycetemcomitans in periodontitis and its association with alveolar bone loss after 6 months of therapy.
Chaves ES; Jeffcoat MK; Ryerson CC; Snyder B
J Clin Periodontol; 2000 Dec; 27(12):897-903. PubMed ID: 11140556
[TBL] [Abstract][Full Text] [Related]
15. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria.
Maeda H; Fujimoto C; Haruki Y; Maeda T; Kokeguchi S; Petelin M; Arai H; Tanimoto I; Nishimura F; Takashiba S
FEMS Immunol Med Microbiol; 2003 Oct; 39(1):81-6. PubMed ID: 14557000
[TBL] [Abstract][Full Text] [Related]
16. Intra- and interspecies regulation of gene expression by Actinobacillus actinomycetemcomitans LuxS.
Fong KP; Chung WO; Lamont RJ; Demuth DR
Infect Immun; 2001 Dec; 69(12):7625-34. PubMed ID: 11705942
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of green tea catechins on protein tyrosine phosphatase in Prevotella intermedia.
Okamoto M; Leung KP; Ansai T; Sugimoto A; Maeda N
Oral Microbiol Immunol; 2003 Jun; 18(3):192-5. PubMed ID: 12753472
[TBL] [Abstract][Full Text] [Related]
18. Effect of periodontal treatments on serum IgG antibody titers against periodontopathic bacteria.
Horibe M; Watanabe H; Ishikawa I
J Clin Periodontol; 1995 Jul; 22(7):510-5. PubMed ID: 7560233
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the pro-inflammatory cytokine-stimulating activity of the surface-associated proteins of periodontopathic bacteria.
Reddi K; Wilson M; Nair S; Poole S; Henderson B
J Periodontal Res; 1996 Feb; 31(2):120-30. PubMed ID: 8708939
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis.
López NJ
J Periodontol; 2000 Jun; 71(6):948-54. PubMed ID: 10914798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
